<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>44</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="epublish">
        <Year>2015</Year>
        <Month>02</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Potential Predictors for Serofast State after Treatment among HIV-Negative Persons with Syphilis in China: A Systematic Review and Meta-Analysis</title>
    <FirstPage>155</FirstPage>
    <LastPage>69</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Jiabi</FirstName>
        <LastName>Qin</LastName>
        <affiliation locale="en_US">Division of Medical Genetics, Maternal and Child Health Hospital of Hunan Province, Hunan, China AND  Skate Key Laboratory of Medical Genetics, Central South University, Hunan, China.</affiliation>
      </Author>
      <Author>
        <FirstName>Tubao</FirstName>
        <LastName>Yang</LastName>
        <affiliation locale="en_US">Dept. of Epidemiology and Health Statistics, School of Public Health, Central South University, Hunan, China.</affiliation>
      </Author>
      <Author>
        <FirstName>Hua</FirstName>
        <LastName>Wang</LastName>
        <affiliation locale="en_US">Division of Medical Genetics, Maternal and Child Health Hospital of Hunan Province, Hunan, China.</affiliation>
      </Author>
      <Author>
        <FirstName>Tiejian</FirstName>
        <LastName>Feng</LastName>
        <affiliation locale="en_US">Dept. of Dermatology and Venereal Disease, Shenzhen Center for Chronic Disease Control and Prevention, Shenzhen, China.</affiliation>
      </Author>
      <Author>
        <FirstName>Xiaoying</FirstName>
        <LastName>Liu</LastName>
        <affiliation locale="en_US">Caimao Hospital of Hunan Province, Hunan, China.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>14</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: Several studies have been conducted in China in order to investigate the potential predictors of serofast state after treatment among syphilitic patients. However, there is a remarkable diversity among the results. This metaanalysis was conducted to assess potential predictors of serofast among syphilitic patients in China. 

Methods: International and national electronic databases were searched up to September 2013. Reference lists of retrieved articles were also reviewed. Cohort or case-control studies addressing risk factors of serofast among syphilitic patients were included in this study. 

Results: We assessed 27 separate studies involving overall 6682 HIV-negative participants with syphilis of which 1962 remained in the serofast state. The serofast was positively associated with older age(Ptrend=0.001), female(summary risk ratio[sRR]=1.50, 95%CI:1.34-1.68), latent syphilis(sRRlatent vs primary=3.17, 95%CI: 2.66-3.77; sRRlatent vs secondary=2.00, 95%CI: 1.48-2.69) as well as non-penicillin treatment(sRR =2.99, 95%CI:2.45-3.67), but negatively associated with higher baseline titers(sRR&gt;1:32 vs &#x2264;1:32=0.63, 95%CI: 0.54-0.75). Compared with healthy group and serological cure group, respectively, the levels of CD4 (+), IL-2, and IL-6 among serofast patients were decreased (standardized mean difference[SMD]&lt;0, P&lt;0.05), but the levels of CD8(+) and IL-10 were increased(SMD&gt;0, P&lt;0.05). Some studies also hinted the serofast was associated with subtypes i of treponema pallidum(TP) repeat gene (RR i vs d=4.67,95%CI: 1.31- 16.69) and TP occult infection. 

Conclusion: The age, gender, stage of infection, baseline titers, treatment drug, cellular immune suppression and disorders, TP occult infection and subtypes i of TP repeat gene should be considered as important predictors of serofast. However, until now the definition and mechanism of serofast has still been not clear.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/3704</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/3704/3378</pdf_url>
  </Article>
</Articles>
